|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
on1258658440 |
| 003 |
OCoLC |
| 005 |
20240808213014.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
210702s2021 sz ob 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d GW5XE
|d OCLCO
|d EBLCP
|d OCLCF
|d DCT
|d UKAHL
|d N$T
|d OCLCO
|d OCLCQ
|d COM
|d CASUM
|d OCLCQ
|d SFB
|d OCLCO
|d OCLCL
|d OCLCQ
|
| 066 |
|
|
|c (S
|
| 019 |
|
|
|a 1266809015
|
| 020 |
|
|
|a 9783030732998
|q (electronic bk.)
|
| 020 |
|
|
|a 3030732991
|q (electronic bk.)
|
| 020 |
|
|
|z 9783030732981
|
| 020 |
|
|
|z 3030732983
|
| 024 |
7 |
|
|a 10.1007/978-3-030-73299-8
|2 doi
|
| 035 |
|
|
|a (OCoLC)1258658440
|z (OCoLC)1266809015
|
| 037 |
|
|
|b Springer
|
| 050 |
|
4 |
|a RD736.S7
|b W45 2021
|
| 072 |
|
7 |
|a MNS
|2 bicssc
|
| 072 |
|
7 |
|a MED065000
|2 bisacsh
|
| 072 |
|
7 |
|a MNS
|2 thema
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Weiss, Jeffrey N.,
|e author.
|
| 245 |
1 |
0 |
|a Orthopedic stem cell surgery /
|c Jeffrey N. Weiss.
|
| 264 |
|
1 |
|a Cham :
|b Springer,
|c [2021]
|
| 264 |
|
4 |
|c ©2021
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|b PDF
|
| 347 |
|
|
|a text file
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 520 |
|
|
|a This book is a concise guide that provides an easy to follow template for other physicians to develop similar stem cell based treatments within their specialty. It identifies and summarizes the current world-wide orthopedic stem cell trials. Organized into three sections, Orthopedic Stem Cell Surgery presents clinical studies that examine the procedures for setting up and implementing stem cell surgery within the specialty of orthopedics. Chapters maintain an accessible narrative while also addressing complex studies related to orthopedic stem cell surgery. A sister text to the recently published, Retinal and Optic Nerve Stem Cell Surgery, and Neurologic Stem Cell Surgery this expertly written book examines critical Institutional Review Board (IRB) approved studies.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (SpringerLink, viewed July 6, 2021).
|
| 505 |
0 |
|
|6 880-01
|a Intro -- Preface -- Contents -- Part I: Rotator Cuff Repair -- 1: Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome -- Functional Outcome -- Patient-Centered Outcome -- Eligibility -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 2: Bone Marrow-Derived Stem Cells for the Treatment of Rotator Cuff Tears -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome -- Inclusion Criteria -- Exclusion Criteria
|
| 505 |
8 |
|
|a 3: Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 4: Safety and Efficacy of Adult Adipose-Derived Stem Cell Injection into Partial-Thickness Rotator Cuff Tears -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 5: Autologous Adult Adipose-Derived Regenerative Cell Injection into Chronic Partial-Thickness Rotator Cuff Tears -- Summary
|
| 505 |
8 |
|
|a Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 6: Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 7: Efficacy of Microfragmented Lipoaspirate Tissue in Arthroscopic Rotator Cuff Repair -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria
|
| 505 |
8 |
|
|a Exclusion Criteria -- 8: Mesenchymal Stem Cells in Rotator Cuff Repair -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 9: Treatment of Tendon Disease Using Autologous Adipose-Derived Mesenchymal Stem Cells -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 10: Adipose-Derived Mesenchymal Stem Cells in Osteoarthritis -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Criteria -- Inclusion Criteria
|
| 505 |
8 |
|
|a Exclusion Criteria -- Part II: Knee Osteoarthritis -- 11: Impact of Mesenchymal Stem Cells in Knee Osteoarthritis -- Summary -- Intervention -- Outcome Measures -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Knee Osteoarthritis Subjects -- Focal Chondral Defect Subjects -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 12: Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES) -- Summary -- Intervention -- Outcome -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria
|
| 650 |
|
0 |
|a Stem cells
|x Therapeutic use.
|
| 650 |
|
0 |
|a Orthopedic surgery.
|
| 650 |
|
7 |
|a Orthopedic surgery
|2 fast
|
| 650 |
|
7 |
|a Cèl·lules mare.
|2 thub
|
| 650 |
|
7 |
|a Ortopèdia.
|2 thub
|
| 655 |
|
7 |
|a Llibres electrònics.
|2 thub
|
| 776 |
0 |
8 |
|i Print version:
|z 3030732983
|z 9783030732981
|w (OCoLC)1241245401
|
| 856 |
4 |
0 |
|u https://holycross.idm.oclc.org/login?auth=cas&url=https://link.springer.com/10.1007/978-3-030-73299-8
|y Click for online access
|
| 880 |
0 |
|
|6 505-01/(S
|a Section 1. Rotator Cuff Repair -- 1. Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair -- 2. Bone Marrow Derived Stem Cells for the Treatment of Rotator Cuff Tears -- 3. Regenexx SD Versus Exercise Therapy for Rotator Cuff Tears -- 4. Safety and Efficacy of Adult Adipose-Derived Stem Cell Injection Into Partial Thickness Rotator Cuff -- 5. Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial- 6. Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus -- 7. Efficacy of Microfragmented Lipoaspirate Tissue in Arthroscopic Rotator Cuff Repair -- 8. Mesenchymal Stem Cells in Rotator Cuff Repair -- 9. Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells -- 10. Adipose-derived Mesenchymal Stem Cells in Osteoarthritis -- Section 2. Knee Osteoarthritis -- 11. Impact of Mesenchymal Stem Cells in Knee Osteoarthritis -- 12. Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES) -- 13. Early Regenerative Intervention for Post-Traumatic Osteoarthritis (ERIPTO) -- 14. Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction -- 15. Open Ended Trocar vs. Fenestrated Blunt Trocar in Bone Marrow Aspirate for Osteoarthriti -- 16. The Effect of Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis -- 17. A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells -- 18. Stem Cell and Growth Factor Injury and Arthritis Clinical Research Study -- 19. Adipose-derived Mesenchymal Stem Cells in Osteoarthritis -- 20. Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis -- 21. A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis (ADIPOA-2) -- 22. Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair (AURA) -- 23. Subchondral and Intra-articular Application of Bone Marrow Concentrate for Knee Unicompartmental OA (Marrow Mule) -- 24. Treatment of Early Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells -- 25. Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis -- 26. Very Small Embryonic-like Stem Cells for Knee Osteoarthritis -- 27. Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis -- 28. Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis -- 29. Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells -- 30. Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis -- 31. Mesenchymal Stem Cell Transplantation for Osteoarthritis -- 32. Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury -- 33. Adipose-derived Stem Cells (ADSCs) for Knee Osteoarthritis -- 34. Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis -- 35. Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis -- 36. Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects -- 37. Follow-up Study for Participants Jointstem Clinical Trial -- 38. A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis -- 39. Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial -- 40. Clinical Study of Intra Articular Injection of Catholic MASTER Cell (Bone Marrow Derived Mesenchymal Stem Cell) in Knee Osteoarthritis (MSC-OA) -- 41. Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial -- 42. Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Compared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients -- 43. Autologous Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis -- 44. The Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Osteoarthritis -- 45. WHARTON JELLY ORIGINATED MESENCHIAL STEM CELL in GONARTHROSIS (WHAMKO) -- 46. Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis -- 47. Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis -- 48. Effects of α MAT Versus Steroid Injection in Knee Osteoarthritis (STα MAT-knee Study) -- 49. Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management -- 50. Comparative Effectiveness of Arthroscopy and Non-Arthroscopy Using Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium for Osteoartrithis (OA) -- 51. The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis -- 52. Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis -- 53. Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis -- 54. BMAC Use With Labral Repair -- Section 3. Labral Repair -- 55. BMAC Use With Labral Repair.
|
| 903 |
|
|
|a SPRING-MED2021
|
| 994 |
|
|
|a 92
|b HCD
|